# IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

> **NCT02228954** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Clear-cell Metastatic Renal Cell Carcinoma
- Kidney Neoplasms

## Interventions

- **PROCEDURE:** Molecular imaging

## Key facts

- **NCT ID:** NCT02228954
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2018-03-05
- **Final completion:** 2021-10-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228954, "IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02228954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*